NCT02880020View on ClinicalTrials.gov

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

December 14, 2016

Primary Completion Date

August 9, 2022

Study Completion Date

August 9, 2022

Conditions

Gastrointestinal Stromal Tumor

Interventions

BIOLOGICAL

Ipilimumab

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Nivolumab

Given IV

Trial Locations (1)

90095

Rachel Andes, Los Angeles

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER